PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34462641-14	2021	The RIP1, RIP3, Drp1, IL-1beta, IL-18, and caspase-1 mRNA levels in the QYSX, 5-ASA, SX, and QY groups were significantly lower than those in the DSS group (P < 0.05), but there were no differences between the QYSX group and the 5-ASA group.	Mesalamine	78-83	interleukin 1 alpha	Mus musculus	22-30	
34874516-10	2022	Meanwhile, HQD-H and 5-ASA significantly decreased the serum IL-1beta, IL-6 and TNF-alpha levels of mice (P<0.05).	Mesalamine	21-26	interleukin 1 alpha	Mus musculus	61-69	
34059563-4	2021	Intrarectal treatment of moderate and severe colitis with 5-ASA alone or HA alone at a dose of 30 mg/kg led to a significant decrease in clinical activity and histology scores, myeloperoxidase activity (MPO), TNF-alpha, IL-6 and IL-1beta in colitis mice compared to untreated animals.	Mesalamine	58-63	interleukin 1 alpha	Mus musculus	229-237	
33138176-8	2020	Intrarectal treatment of colitis with 30 mg/kg chitosan alone and with 30 mg/kg 5-ASA for 3 days led to a significant decrease in MPO, ALP, TNF-alpha, IL-6, IL-1beta and NF-kappaB in colitis mice compared to untreated mice.	Mesalamine	80-85	interleukin 1 alpha	Mus musculus	157-165